NAVLE Nervous

Cervidae and Camelidae Chronic Wasting Disease Study Guide

Chronic wasting disease (CWD) is a fatal, progressive neurodegenerative prion disease affecting members of the family Cervidae (deer, elk, moose, reindeer, and caribou).

Overview and Clinical Importance

Chronic wasting disease (CWD) is a fatal, progressive neurodegenerative prion disease affecting members of the family Cervidae (deer, elk, moose, reindeer, and caribou). First identified in captive mule deer in Colorado in 1967, CWD has since spread to 36 US states, 5 Canadian provinces, South Korea, Norway, Finland, and Sweden. Unlike other transmissible spongiform encephalopathies (TSEs), CWD is unique in affecting free-ranging wildlife and demonstrating efficient horizontal transmission through environmental contamination.

CWD represents a significant topic on the NAVLE and BCSE examinations due to its zoonotic potential concerns, regulatory importance, diagnostic challenges, and wildlife management implications. Understanding the pathophysiology, clinical presentation, diagnostic approach, and management strategies is essential for veterinary practice.

Important Note on Camelidae: While CWD naturally affects cervids, camelids (llamas and alpacas) share grazing environments with cervids in some regions. Current evidence indicates that CWD does NOT naturally affect camelids, and no natural cases have been documented. However, camelids may be exposed to environmental prion contamination in CWD-endemic areas, making this a relevant differential consideration.

Characteristic Clinical Significance
No nucleic acid Prions contain only protein, no DNA or RNA; cannot be detected by PCR
Extreme resistance Resistant to heat, radiation, formaldehyde, proteases, and standard disinfection; scrapie prion shown to persist 16+ years in environment
No immune response Does not evoke traditional immune response; no antibody production; no vaccine available
Soil binding Prions bind tightly to clay minerals in soil; may enhance infectivity; environmental reservoirs persist
Protease resistance PrPSc is partially resistant to proteinase K digestion; forms basis of diagnostic testing

Etiology and Pathophysiology

Prion Biology

CWD is caused by prions (proteinaceous infectious particles), which are misfolded isoforms of the normal cellular prion protein (PrPC). The disease-associated misfolded form is designated PrPSc (for scrapie) or PrPCWD. When PrPCWD contacts normal PrPC, it induces conformational change, converting the normal protein to the pathogenic form in a self-propagating chain reaction.

Key Prion Characteristics

High-YieldUnlike bacteria and viruses, prions contain NO nucleic acid and cannot be detected by PCR. Diagnosis relies on detection of the misfolded protein itself through immunological methods (ELISA, IHC) or amplification assays (RT-QuIC, PMCA).

Pathogenesis

Following oral exposure (the primary natural route), CWD prions are taken up by gut-associated lymphoid tissue (GALT), particularly Peyer's patches. The agent then spreads to other lymphoid tissues including tonsils, retropharyngeal lymph nodes, and spleen. PrPCWD accumulates in lymphoid tissues early in infection, often months to years before CNS involvement.

Neuroinvasion occurs via retrograde transport along autonomic nerves, primarily the vagus nerve. The dorsal motor nucleus of the vagus at the obex region of the medulla oblongata is typically the first CNS site affected. From there, prions spread throughout the brain, causing progressive neurodegeneration characterized by:

  • Spongiform change (vacuolation) in gray matter neuropil
  • Intraneuronal vacuolation (perikaryon vacuoles)
  • Neuronal degeneration and loss
  • Astrocytic hypertrophy and hyperplasia (astrogliosis)
  • Amyloid plaque deposition (more common in deer than elk)
  • Absence of inflammatory response (no infiltration of inflammatory cells)
NAVLE TipKey histopathologic features of TSEs: spongiform change + astrogliosis + neuronal loss + NO inflammation. The absence of inflammatory response distinguishes prion diseases from viral encephalitides.
Species Scientific Name Notes
Mule deer Odocoileus hemionus First species identified; high prevalence in endemic areas
White-tailed deer Odocoileus virginianus Most studied; significant PRNP polymorphism effects
Rocky Mountain elk Cervus canadensis nelsoni Codon 132 polymorphism affects susceptibility
Moose Alces alces Rare natural cases; atypical strains in Scandinavia
Reindeer Rangifer tarandus tarandus First European cases in Norway (2016)
Red deer Cervus elaphus elaphus Susceptible; cases in captive populations
Sika deer Cervus nippon Cases in South Korea from imported elk
Caribou Rangifer tarandus spp. No natural cases; likely susceptible based on genetics

Susceptible Species and Genetic Factors

Naturally Susceptible Cervid Species

PRNP Gene Polymorphisms and Susceptibility

The PRNP gene encodes the prion protein and contains polymorphisms that significantly affect CWD susceptibility, incubation time, and disease progression. Understanding these polymorphisms is essential for disease management and selective breeding programs.

Memory Aid - PRNP Polymorphisms: "ELK 132, DEER 95-96" - Elk susceptibility determined at codon 132 (M>L); White-tailed deer at codons 95 and 96. Wild-type genotypes = most susceptible, shortest incubation.

Camelidae and CWD Susceptibility

Important: New World camelids (llamas, alpacas, guanacos, vicunas) are NOT known to be naturally susceptible to CWD. No natural cases have been documented despite habitat overlap with cervids in some regions. Key considerations:

  • Camelid PrP differs significantly from cervid PrP at key amino acid positions
  • No experimental transmission studies have demonstrated CWD susceptibility in camelids
  • Environmental prion contamination in shared grazing areas is a theoretical concern
  • Avoid feeding bone meal to camelids as a precautionary measure against TSE exposure

Species NOT Naturally Affected by CWD

  • Domestic cattle - Highly resistant via oral route; some susceptibility via intracerebral inoculation
  • Sheep and goats - Have their own prion disease (scrapie); CWD transmission requires intracerebral inoculation
  • Camelids - No natural cases; appear resistant
  • Horses - Not susceptible
  • Humans - Strong species barrier; no confirmed cases, but surveillance ongoing
Species Codon Effect
Elk 132 (M/L) MM132 = most susceptible; ML132 = 2x incubation; LL132 = 3x incubation
White-tailed deer 95 (Q/H) 95H allele = prolonged incubation; may select for altered prion strains
White-tailed deer 96 (G/S) 96S allele = delayed disease onset; QQ95GG96 (wild-type) = shortest incubation (~23 months)
Mule deer 225 (S/F) SS225 = shorter incubation (16 months); SF225 = longer incubation (greater than 25 months)
Reindeer/Caribou 138 (S/N) 138N allele = protective; 138NN or 138SN = reduced susceptibility

Transmission Routes

CWD is considered the most contagious of all prion diseases due to efficient horizontal transmission and environmental persistence. Understanding transmission is critical for disease management.

High-YieldPrion shedding begins during the PRECLINICAL phase, often months before clinical signs appear. This makes subclinical carriers a major source of environmental contamination. Incubation period is typically 18-24 months, with animals as young as 15 months showing clinical disease.
Route Details
Direct Contact Animal-to-animal contact; nose-to-nose contact; grooming behavior; social interactions
Saliva Major shedding route; infectious prions detected as early as 9 months post-infection; contaminated feed/water sources
Urine Prions shed in urine; polydipsia/polyuria in clinical animals increases environmental contamination
Feces Prions detected in feces; pasture contamination; prion shedding begins during preclinical phase
Environmental Prions bind to soil clay particles; remain infectious for years (potentially 16+ years); pastures remain contaminated after removal of infected animals
Vertical (Maternal) In utero transmission documented; up to 80% of fetuses from CWD-positive elk dams found positive; placental and fetal tissues contain prions
Carcass/Offal Decomposing carcasses contaminate environment; hunter-harvested gut piles; antler velvet contains prions
Vectors Ticks may harbor prions; crows/scavengers can spread prions in feces; plants can uptake prions from soil

Clinical Signs

Clinical signs of CWD are subtle, progressive, and nonspecific, making clinical diagnosis unreliable. The disease course is always fatal, typically over weeks to months after onset of clinical signs. Most affected animals are adults greater than 16 months old.

Classic Clinical Presentation

Memory Aid - CWD Clinical Signs "WASTED": Weight loss progressive, Ataxia and tremors, Salivation excessive, Thirst increased (polydipsia), Ears drooping, Death inevitable

APHIS Clinical Summary: "Behavioral changes, emaciation, weakness, ataxia, salivation, aspiration pneumonia, progressive death."

NAVLE TipCWD should be suspected in ANY adult cervid presenting with aspiration pneumonia, especially with concurrent weight loss. Aspiration pneumonia is often the direct cause of death in CWD-affected animals due to difficulty swallowing.
Category Clinical Signs
Body Condition Progressive weight loss (wasting); emaciation; poor body condition despite adequate feed availability; rough hair coat
Behavioral Decreased interaction with herd; isolation; listlessness; loss of fear of humans; confusion; repetitive walking patterns; nervousness
Neurologic Ataxia (incoordination); head tremors; wide-based stance; lowered head carriage; drooping ears; difficulty swallowing; teeth grinding
Gastrointestinal Excessive salivation (ptyalism/drooling); apparent ruminal atony; flaccid hypotonic facial muscles
Urinary Polydipsia (increased drinking); polyuria (increased urination) - contributes to environmental contamination
Terminal Severe cachexia; recumbency; aspiration pneumonia (common cause of death); death following acute stressors

Diagnosis

Clinical diagnosis of CWD is unreliable due to nonspecific signs. Definitive diagnosis requires laboratory detection of PrPCWD in tissues, primarily postmortem.

Diagnostic Methods

Tissues for Testing

Primary postmortem tissues:

  • Obex (brainstem at level of dorsal motor nucleus of vagus) - earliest CNS site affected
  • Medial retropharyngeal lymph nodes (MRPLN) - lymphoid tissue; early prion accumulation; BOTH nodes should be tested

Antemortem tissues (research/limited use):

  • Rectal mucosa biopsy (RAMALT - recto-anal mucosa-associated lymphoid tissue)
  • Tonsil biopsy
  • Third eyelid - contains lymphoid follicles; easier to collect than MRPLN
  • Saliva, urine, feces, blood - RT-QuIC detection; research applications
High-YieldThe USDA-approved diagnostic protocol requires ELISA screening of obex and/or retropharyngeal lymph nodes, with IHC confirmation of positive results. Testing BOTH medial retropharyngeal lymph nodes is important because asymmetric prion distribution can lead to false-negatives when only one node is tested.

Differential Diagnoses

  • Malnutrition/starvation - environmental conditions; inadequate feed
  • Parasitism - heavy GI parasite burden; meningeal worm (Parelaphostrongylus tenuis)
  • Dental disease - prevents adequate feed intake
  • Epizootic hemorrhagic disease (EHD)/Bluetongue
  • Tuberculosis
  • Neoplasia
  • Capture myopathy - note: death after chemical immobilization has been observed in CWD-positive animals
  • Chronic liver or kidney disease
Method Description Notes
IHC Immunohistochemistry - detects PrPCWD in tissue sections using antibodies; visualizes pathology GOLD STANDARD; required for USDA confirmation; performed on obex and/or retropharyngeal lymph nodes
ELISA Enzyme-linked immunosorbent assay - sandwich ELISA detecting PrPCWD in tissue homogenates Primary screening test for surveillance; positive results require IHC confirmation; high throughput
RT-QuIC Real-time quaking-induced conversion - amplifies misfolded prions using recombinant PrP substrate; detected by thioflavin T fluorescence Highly sensitive; can detect prions in multiple tissues, fluids, and excreta; promising for antemortem testing; not yet USDA-approved
Western Blot Electrophoretic separation and immunodetection of protease-resistant PrP Specific; can differentiate strains; time-consuming; not suitable for high-throughput screening
PMCA Protein misfolding cyclic amplification - serial sonication cycles amplify prions Very sensitive; generates infectious prions; research use; not approved for routine diagnostics
Histopathology H&E staining to visualize spongiform change, vacuolation, astrogliosis Insensitive for subclinical disease; lesions only present at clinical stage; autolysis impairs interpretation

Treatment, Prevention, and Management

There is NO treatment, vaccine, or cure for CWD. The disease is invariably fatal. Management focuses on surveillance, containment, and prevention of spread.

Prion Decontamination

Prions are extremely resistant to conventional disinfection. Recommended methods for contaminated surfaces/equipment:

  • Sodium hypochlorite (household bleach) - 20,000 ppm available chlorine, 1 hour contact time
  • Sodium hydroxide - 1-2N NaOH, 1 hour contact time
  • Autoclaving - 134°C for 18 minutes (porous load) or 1 hour (gravity displacement)
  • Incineration - preferred for carcasses and heavily contaminated materials

Public Health Considerations

No confirmed human cases of CWD have been documented. However, given the zoonotic transmission of BSE to humans (variant CJD), precautions are recommended:

  • Do not consume meat from animals that appear sick or test positive
  • Have deer tested before consumption in endemic areas
  • Avoid consumption of high-risk tissues (brain, spinal cord, eyes, spleen, tonsils, lymph nodes)
  • Use proper precautions when field-dressing and processing carcasses
  • NIH studies suggest substantial species barrier; human cerebral organoids resistant to CWD transmission
Strategy Details
Surveillance Hunter-harvested testing programs; targeted culling in endemic areas; mandatory testing zones; road-kill sampling
Herd Certification USDA National CWD Voluntary Herd Certification Program for farmed cervids; required for interstate movement; 5-year monitoring requirement
Depopulation Affected captive herds typically depopulated; quarantine followed by euthanasia; indemnity programs available in some jurisdictions
Population Reduction Targeted culling to reduce deer density in endemic areas; may help slow transmission but cannot eliminate environmental prion reservoir
Movement Restrictions Regulations on transport of live cervids; carcass import restrictions; prohibition on transport of high-risk tissues from endemic areas
Feeding Bans Prohibition of supplemental feeding/baiting; prevents congregation of animals; reduces direct transmission opportunities; reduces environmental contamination at feeding sites
Selective Breeding Breeding for less susceptible PRNP genotypes in farmed herds (white-tailed deer: 96S allele); research ongoing but shows promise
Carcass Disposal Proper disposal of hunter-harvested carcasses; incineration programs; designated disposal dumpsters for high-risk tissues; avoid disposing on landscape

Regulatory Status

  • Reportable disease in most US states and Canadian provinces
  • USDA-APHIS regulates interstate movement of farmed cervids
  • State wildlife agencies manage CWD in free-ranging populations
  • Not listed as OIE notifiable disease (no international movement restrictions)

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →